Advanced Filters
noise
Found 811 clinical trials
D DUMURGIER Julien, MD, PhD

Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

Donepezil, as well as the other symptomatic drugs of Alzheimer's disease, is not any more reimbursed by the French healthcare system, due to a controversy about its efficiency. French health authorities currently preconize a non-rug approach based on cognitive remediation or stimulation. The aim of this study is to compare …

50 years of age All Phase 3
N Navin Kaushal, PhD

Caring for Caregivers of Individuals With Alzheimer's Disease

What is this study about? This study is called the EMBRACE Study - A Virtual Community Empowerment Approach Integrating Tradition and Technology for Family Caregivers of Individuals with Alzheimer's Disease. It tests whether a home-based virtual exercise program can reduce depression and anxiety in family caregivers of people living with …

18 - 99 years of age All Phase N/A
J Jessica St. Romain, MA

Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

The RAATE proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. There are three main objectives of the protocol: 1) to determine if a physical …

60 years of age All Phase N/A
D Dr Gundersen, MBChB

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.

18 years of age All Phase 1
C Craig Ritchie, Professor, MD, PhD

A Study to Assess THN391 in Subjects With Alzheimer's Disease

This is a Phase 1b study to evaluate different doses of the drug and see whether a drug is safe and how it behaves in the body. THN391 has already been assessed in healthy people without Alzheimer's disease. This is the first study of THN391 in patients with Early Alzheimer's …

65 - 85 years of age All Phase 1
C Chiu Wing CHU, MBChB, MD

Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis

The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach …

55 years of age All Phase N/A

MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease

Patients with Mild Cognitive Impairment (MCI) or Subjective Cognitive Decline (SCD) may or may not develop Alzheimer's disease (AD) dementia. Yet identifying patients at risk is crucial: delaying the onset of the disease by 5 years could reduce prevalence by 50%. To achieve this, we need affordable biomarkers combined with …

50 - 80 years of age All Phase N/A

Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?

Alzheimer's disease (AD) is characterised by a progressive loss of memory and cognitive function. In the early stages of AD, there is a progressive accumulation of molecules: β-amyloid peptides (Aβ) in the brain. There is a link between the accumulation of Aβ peptides and the deterioration of sleep, but current …

50 - 85 years of age All Phase N/A
M Maria Stefania De Simone, Dr

REducing the Risk of COgnitive DEcline ad Dementia in Patients With Subjective Cognitive Decline Through an Immersive Virtual Reality and Telemedicine-based Multi-component Intervention: the SCD-ReCODED Study

Older adults with subjective cognitive decline (SCD) are at high risk of developing dementia and frequently experience subclinical symptoms (e.g., anxiety, depression) which are themselves associated with dementia and cognitive decline risk. To date, the lack of effective disease-modifying treatments, along with the reliable identification of modifiable lifestyle risk factors …

55 - 80 years of age All Phase N/A
J Jung-Ah Lee, PhD

Dementia Family Caregiver Study

The proposed study will test a 3-month, community health worker (CHW) delivered home visit, culturally and language-appropriate intervention for ethnic and underserved dementia family caregivers of persons with dementia (PWD) using wearable technology for real time monitoring of caregivers' stress and sleep. The CHW delivered home visit intervention includes stress …

18 years of age All Phase N/A

Simplify language using AI